Bank of Montreal’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,182
Closed -$41K 5254
2019
Q1
$41K Sell
2,182
-5,918
-73% -$96K ﹤0.01% 3421
2018
Q4
$110K Buy
+8,100
New +$90.5K ﹤0.01% 2908
2016
Q3
Sell
-19,860
Closed -$101K 4390
2016
Q2
$101K Hold
19,860
﹤0.01% 2796
2016
Q1
$113K Buy
19,860
+9,015
+83% +$63K ﹤0.01% 2747
2015
Q4
$113K Sell
10,845
-5,523
-34% -$75K ﹤0.01% 2722
2015
Q3
$302K Sell
16,368
-3,776
-19% -$72.9K ﹤0.01% 2072
2015
Q2
$392K Buy
20,144
+16,274
+421% +$288K ﹤0.01% 2093
2015
Q1
$68K Buy
+3,870
New +$65K ﹤0.01% 2800
2014
Q3
Sell
-400
Closed -$6K 4946
2014
Q2
$6K Buy
+400
New +$5.88K ﹤0.01% 4141
2013
Q4
Sell
-100
Closed -$2K 4167
2013
Q3
$2K Buy
+100
New +$1.48K ﹤0.01% 3705

Other funds holding OSIR

Bank of Montreal's OSIR Position: Q2 2019 in Review

Bank of Montreal sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 2,182 shares — an estimated $41K sold.

Bank of Montreal first reported a position in OSIR in Q3 2013 and held it in 10 quarters. The position peaked at $392K in Q2 2015. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Bank of Montreal reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Bank of Montreal sold 2,182 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $41K.
  • Bank of Montreal first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 10 quarters.
  • Bank of Montreal's Osiris Therapeutics, Inc. Common Stock position peaked at $392K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.